Skip to main content
Log in

KHK inhibition for the treatment of hereditary fructose intolerance and nonalcoholic fatty liver disease: a double-edged sword

  • Commentary
  • Published:
Cellular and Molecular Life Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Buziau AM, Schalkwijk CG, Stehouwer CDA et al (2019) Recent advances in the pathogenesis of hereditary fructose intolerance: implications for its treatment and the understanding of fructose—induced non: alcoholic fatty liver disease. Cell Mol Life Sci. https://doi.org/10.1007/s00018-019-03348-2

    Article  PubMed  Google Scholar 

  2. Distefano JK (2019) Fructose-mediated effects on gene expression and epigenetic mechanisms associated with NAFLD pathogenesis. Cell Mol Life Sci 1:3. https://doi.org/10.1007/s00018-019-03390-0

    Article  CAS  Google Scholar 

  3. Lanaspa MA, Johnson RJ, Tolan DR et al (2018) Ketohexokinase C blockade ameliorates fructose-induced metabolic dysfunction in fructose-sensitive mice find the latest version: Ketohexokinase C blockade ameliorates fructose- induced metabolic dysfunction in fructose-sensitive mice. J Clin Invest 128:2226–2238

    Article  Google Scholar 

  4. Patel C, Douard V, Yu S et al (2015) Transport, metabolism, and endosomal trafficking dependent regulation of intestinal fructose absorption. FASEB J 29:4046–4058. https://doi.org/10.1096/fj.15-272195

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Jang C, Hui S, Lu W et al (2018) The small intestine converts dietary fructose into glucose and organic acids. Cell Metab 27:351–361.e3. https://doi.org/10.1016/j.cmet.2017.12.016

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Zhang X, Grosfeld A, Williams E et al (2019) Fructose malabsorption induces cholecystokinin expression in the ileum and cecum by changing microbiota composition and metabolism. FASEB J. https://doi.org/10.1096/fj.201801526RR

    Article  PubMed  PubMed Central  Google Scholar 

  7. Demirbas D, Brucker WJ, Berry GT (2018) Inborn errors of metabolism with hepatopathy. Pediatr Clin North Am 65:337–352. https://doi.org/10.1016/j.pcl.2017.11.008

    Article  PubMed  Google Scholar 

  8. Aldamiz-Echevarria L, de Heraslas J, Couce ML et al (2019) Clinical nutrition non-alcoholic fatty liver in hereditary fructose intolerance. Clin Nutr. https://doi.org/10.1016/j.clnu.2019.02.019

    Article  PubMed  Google Scholar 

  9. Di DF, Spadarella S, Puoti MG et al (2019) Daily fructose traces intake and liver injury in children with hereditary fructose intolerance. Nutrients 11:1–12. https://doi.org/10.3390/nu11102397

    Article  CAS  Google Scholar 

  10. Schwarz J-M, Noworolski SM, Erkin-Cakmak A et al (2017) Effects of dietary fructose restriction on liver fat, de novo lipogenesis, and insulin kinetics in children with obesity. Gastroenterology 153:743–752. https://doi.org/10.1053/j.gastro.2017.05.043

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Franciele Cabral Pinheiro.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pinheiro, F.C., Sperb-Ludwig, F. & Schwartz, I.V.D. KHK inhibition for the treatment of hereditary fructose intolerance and nonalcoholic fatty liver disease: a double-edged sword. Cell. Mol. Life Sci. 77, 3465–3466 (2020). https://doi.org/10.1007/s00018-020-03575-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00018-020-03575-y

Navigation